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Abstract
Background
Women attending antenatal care (ANC) in resource-limited countries are frequently
screened for syphilis and HIV, but rarely for other sexually transmitted infections (STIs). We
assessed the prevalence of curable STIs, defined as infection with either Chlamydia tracho-
matis or Neisseria gonorrhoeae or Trichomonas vaginalis, from July to September 2015.
Methods
In a cross-sectional study, women attending ANC at the Kilifi County Hospital, Kenya, had a
urine sample tested for C. trachomatis/N. gonorrhoeae by GeneXpert® and a vaginal swab
for T. vaginalis by culture. Bacterial vaginosis (BV) was defined as a Nugent score of 7–10
of the Gram stain of a vaginal smear in combination with self-reported vaginal discharge.
Genital ulcers were observed during collection of vaginal swabs. All women responded to
questions on socio-demographics and sexual health and clinical symptoms of STIs. Predic-
tors for curable STIs were assessed in multivariable logistic regression.
Results
A total of 42/202 (20.8%, 95% confidence interval (CI):15.4–27.0) women had a curable
STI. The prevalence was 14.9% for C. trachomatis (95% CI:10.2–20.5), 1.0% for N. gonor-
rhoeae (95% CI: 0.1–3.5), 7.4% for T. vaginalis (95% CI:4.2–12.0), 19.3% for BV (95% CI:
14.1–25.4) and 2.5% for genital ulcers (95% CI: 0.8–5.7). Predictors for infection with cur-
able STIs included women with a genital ulcer (adjusted odds ratio (AOR) = 35.0, 95% CI:
2.7–461.6) compared to women without a genital ulcer, women who used water for cleaning
after visiting the toilet compared to those who used toilet paper or other solid means (AOR =
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4.1, 95% CI:1.5–11.3), women who reported having sexual debut 17 years compared to
women having sexual debut18 years (AOR = 2.7, 95% CI:1.1–6.6), and BV-positive
women (AOR = 2.7, 95% CI:1.1–6.6) compared to BV-negative women.
Conclusion
One in five women attending ANC had a curable STI. These infections were associated with
genital ulcers, hygiene practices, early sexual debut and bacterial vaginosis.
Introduction
Sexually transmitted infections (STIs) are a major public health concern globally and especially
among women in resource-limited countries [1]. Common curable STIs among women in
sub-Saharan Africa (sSA) include Chlamydia trachomatis, Neisseria gonorrhoeae and Tricho-
monas vaginalis [2]. Additionally, bacterial vaginosis (BV), which has been associated with an
increased risk of incident infection with C. trachomatis and N. gonorrhoeae [3, 4], is highly
prevalent [5]. These curable STIs and BV have been associated with a number of adverse preg-
nancy outcomes such as spontaneous abortion, ectopic pregnancy, preterm delivery, low birth
weight, stillbirth, postpartum sepsis, and congenital infection [6]. Infants born of mothers with
genital C. trachomatis are at an increased risk of suffering from neonatal pneumonia and oph-
thalmia neonatorum [7]. At present the efficacy of neonatal ocular prophylaxis with erythro-
mycin for prevention of C. trachomatis ophthalmia is not clear [8]. These associated sequelae
of STIs hence necessitate prevention and management of curable STIs and BV, especially dur-
ing pregnancy.
Pregnant women attending antenatal care (ANC) in resource-limited countries are fre-
quently screened for syphilis [9] and HIV [10], but rarely for other curable STIs or BV. More-
over, curable STIs and BV are associated with increased acquisition and transmission of HIV
[11–13]. Among pregnant HIV positive women C. trachomatis is associated with increased
risk of HIV mother-to-child transmission [14]. Many resource-limited countries have adopted
the World Health Organization’s syndromic approach for the management of curable STI
[15]. This syndromic approach is deficient in both sensitivity and specificity because STIs may
be asymptomatic or have non-specific clinical signs and symptoms [16, 17].
There is a paucity of epidemiological and risk factor data on curable STIs among women
residing in rural areas, including among pregnant women in coastal Kenya. Most of the recent
information about the prevalence of curable STIs among women in Kenya has been from stud-
ies done among high-risk individuals [18], women residing in cities [19, 20] or from regions
with high incidence of HIV [13]. Consequently, we assessed the prevalence and predictors of
curable STIs in pregnant women attending ANC at a rural county hospital in Coastal Kenya.
Methods
This was a cross-sectional study conducted from July to September 2015, at the ANC clinic of
the Kilifi County Hospital (KCH), Kenya, a clinic attended to by approximately 4,000 women
annually [21]. We aimed to enroll a convenience sample of 350 consecutive pregnant women
to identify 20–25 women with T. vaginalis for detailed molecular studies of T. vaginalis and
assessment of the vaginal microbiome. Here, we report on a sub-study of 202 women who
were tested for curable STIs, i.e. C. trachomatis, N. gonorrhoeae, T. vaginalis, and for BV.
Curable sexually transmitted infections among pregnant women in Kilifi, Kenya
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Procedures
Recruitment: A nurse at the ANC clinic provided general information about the study to
women who had completed their ANC visit. Women interested to know more about the study
were invited to participate and up to nine consecutive women were enrolled per day.
Inclusion criteria: Women were eligible if they met the following criteria: age 18–45 years,
gestation 14 weeks, resident of the Kilifi Health and Demographic Surveillance area [22]
and willing to undergo free STI and BV screening procedures.
Study procedures: Consenting women underwent a short private interview with the nurse
at the ANC clinic using a structured questionnaire capturing symptoms of vaginal infections.
This was followed by a collection of vaginal swabs by the ANC nurse. During the collection of
vaginal swabs, the nurse observed for abnormal vaginal discharge and genital ulcers. Three
vaginal swabs were collected, by inserting one swab at a time approximately 2 inches into the
vaginal opening and gently turning around twice ensuring rubbing the swab against the vagi-
nal wall.
The first swab was used for BV diagnosis and vaginal smears were prepared by rolling the
swab onto a microscope glass slide. Slides were air-dried at the clinic before being transported
to the laboratory for heat fixation followed by Gram staining and microscopy using the scoring
system described by Nugent [23]. Women who self-reported discharge and had a Nugent
score of 7–10 were considered BV-positive, and were treated as recommended [8]. Women
with a Nugent score of 7–10 but without discharge were considered BV-negative.
The second swab was used to diagnose T. vaginalis using a commercially available T. vagi-
nalis InPouchTM system (BioMed Diagnostics, White City, Oregon, USA). The vaginal swab
was inoculated in the upper-chamber of the InPouch at the clinic. The inoculated InPouch was
transferred to the laboratory for direct microscopy of the upper chamber, after which the
upper chamber was merged with the lower chamber and incubated at 37˚C. Daily microscopy
was performed and samples with motile trichomonads within 5 days of culture were consid-
ered positive for T. vaginalis.
The third swab was placed in a sterile labeled 2 ml Eppendorf tube, the swab shaft was broken
by bending the shaft against the neck of the Eppendorf tube. The bottom portion of the swab with
the specimen was transported to the laboratory where it was immediately stored at -80˚C for
molecular studies of the vaginal microbiome. No transport or freezing medium was added.
Women provided fresh first catch urine for C. trachomatis and N. gonorrhoeae testing, that
was performed by the GeneXpert1 CT/NG Assay (Cepheid, Sunnyvale, California), according
to the manufacturer’s instructions.
Results for C. trachomatis, N. gonorrhoeae, for T. vaginalis direct microscopy and for BV
were reported on the same day of the visit, and STI and BV treatment was offered according to
Kenyan national guidelines [24], except for treatment of N. gonorrhoeae where ceftriaxone was
used in place of quinolones [25]. Women who were negative on T. vaginalis direct microscopy
but positive on culture were contacted to return to the ANC clinic for treatment immediately
after the culture turned positive. Treatment was also offered for the partners of the women
with curable STIs.
Syphilis and HIV test results were obtained from each participant’s ANC records. Syphilis
results were based on testing for treponemal antibodies only, done at the hospital laboratory
using a commercial test kit Advanced Quality One Step Anti-TP (InTec products INC, Xia-
men, China). Rapid HIV testing was done by the Alere Determine HIV-1/2 kit (Alere Medical
Co Ltd, Chiba, Japan), the First response HIV 1-2-0 kit (Premier Medical Corporation Lim-
ited, Daman, India) was used to confirm positive results, and the Uni-Gold kit (Trinity Bio-
tech, Wicklow, Ireland) was used to resolve any discordant test results.
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After clinical procedures were completed, all study participants were interviewed. The
interviews were conducted in Kiswahili by a trained female fieldworker. The questionnaire
covered sociodemographic, hygienic and sexual behavior questions. These included age, edu-
cation level, marital status, number of children, occupation, consumption of alcohol, con-
sumption of tobacco and other substances, age at first sex, number of sexual partners, history
of STIs, and hygiene and sanitary practices.
Ethical considerations
The study was approved by the KEMRI Scientific and Ethics Review Unit (#3022). All partici-
pants provided written informed consent for study participation. Permission to use hospital
records on syphilis and HIV status was obtained from Kilifi County Health department.
Data analysis
Data were entered in the REDCapTM electronic data capture tool, version 6.5.0 (Vanderbilt
University, Nashville, Tennessee). Prevalence of STIs was determined as the number of partici-
pants with either C. trachomatis, N. gonorrhoeae and/or T. vaginalis out of 202 women that
could be tested, expressed as a percentage. Exact 95% binomial confidence intervals (CIs) were
calculated for prevalence estimates. Bivariable logistic regression was used to determine associ-
ations of sociodemographic, hygienic, behavioral and clinical characteristics with curable STIs.
Variables significant at p 0.1 in bivariable analysis were entered into a multivariable model
to identify independent associations. Crude odds ratios (COR) and adjusted odds ratios
(AOR) were calculated. These statistical analyses were done using STATA version 13.1 (Stata-
Corp, College Station, Texas).
Results
From June to September 2015, a total of 373 women were invited to participate in the study.
Twenty-three (6.2%) women declined to participate citing no interest in research, lacking time or
having no permission from spouse/partner as the main reasons. Of the 350 women enrolled, 148
(42.3%) women did not have C. trachomatis and N. gonorrhoeae tests performed due the unavail-
ability of the tests at the beginning of the study. Therefore, a total of 202 women were tested for
C. trachomatis, N. gonorrhoeae, T. vaginalis and BV and were included in this sub-analysis (Fig 1).
Characteristics of the study population
The median age and gestation age including the interquartile range (IQR) for the participants
was 26 (22–31) years and 24 (20–28) weeks respectively. The majority of the participants were
married (93.6%) and Christian (72.3%). A quarter of the participants had secondary school
education and above. The median age and IQR of sexual debut was 18 (16–20) years, although
20.8% of the participants were not sure or did not respond to this question. Forty-two percent
of the participants had given birth before and the number of children ranged from 1–7. Sixty-
two percent of the participants had previously experienced signs/symptoms associated with
reproductive tract infection and one third had ever received syndromic treatment for genital
signs or symptoms of infection. The socio-demographic characteristics of the participants are
summarized in Table 1.
Prevalence of curable STIs, BV, HIV and syphilis
A total of 20.8% (42/202) (95% confidence interval (CI): 15.4–27.0) women had a curable STI
and 19.4% (39/202) (95% CI: 14.2–25.6) women had BV i.e. Nugent score of 7–10 and reported
Curable sexually transmitted infections among pregnant women in Kilifi, Kenya
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vaginal discharge. The prevalence was 14.9% for C. trachomatis (95% CI: 10.2–20.5), 1.0% for
N. gonorrhoeae (95% CI: 0.1–3.5) and 7.4% for T. vaginalis (95% CI: 4.2–12.0) (Fig 1). Five
(11.9%) women had more than one STI, while 13 (31%) out of the 42 women with a curable
STI also had BV. Only two women (1.0%) had asymptomatic BV and none of them had a cur-
able STI (data not shown).
Thirteen women were HIV-positive, a prevalence of 6.4% (95% CI: 3.4–10.8), including
four (2.0%; 95% CI: 0.5–5.0) women who were newly diagnosed. Of note, HIV prevalence in
82 women aged 18–24 vs. 120 women aged 25 years was 0% vs. 10.8% (p = 0.002). All nine
HIV positive women who knew their status were on anti-retroviral therapy. Among the 13
women with HIV, three women had curable STIs, i.e. a prevalence of 23.1% (95% CI: 5.0–
53.8). All women with HIV and a curable STI also had BV. The prevalence of curable STIs, or
BV in the 13 women with HIV was not statistically significantly different from that of the 189
women without HIV (data not shown).
Two women had treponemal antibodies, a prevalence of 1.0% (95% CI: 0.1–3.6). Prevalence
of HIV, treponemal antibodies and T. vaginalis for the 148 women who were not tested for C.
trachomatis and N. gonorrhoeae was not statistically significantly different than the prevalence
of HIV, syphilis, and T. vaginalis in the 202 tested for C. trachomatis and N. gonorrhoeae in the
sub-study.
Clinical signs and symptoms
The most commonly self-reported symptoms amongst all participants were vaginal discharge
(73.8%) and lower abdominal pain (46.5%). However, during collection of specimen by the
study nurse, only 17.3% of the participants had an abnormal discharge (defined as excess
Fig 1. Flow chart of women attending antenatal care clinic at Kilifi County Hospital invited to
participate in the study, June- September 2015
https://doi.org/10.1371/journal.pone.0175166.g001
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Table 1. Socio-demographic, hygienic, and behavioral characteristics of 202 women attending ante-
natal care and tested for sexually transmitted infections and bacterial vaginosis in Kilifi County Hos-
pital, Kenya, July-September 2015.
Total
n = 202
Positive for curable STIs n = 42
(%)
Demographic characteristics
Age group (Years)
18–24 82 24 (29.3)
 25 120 18 (15.0)
Religion
Christian 146 28(19.2)
Muslim 28 7 (25.0)
Other/None 28 7 (25.0)
Education
None 35 7 (20.0)
Primary 118 26 (22.0)
Secondary/Tertiary 49 9 (18.4)
Marital status
Single 13 5 (38.5)
Married 189 37 (19.6)
Residency
Living with partner 138 27 (19.6)
Not living with the partner 64 15 (23.4)
Employment status
Employed/self-employed 115 20 (17.4)
Unemployed 87 22 (25.3)
Parity
0 58 15 (25.9)
1–2 69 17 (24.6)
3+ 75 10 (13.3)
Gestational age (weeks)**
14–25 114 24 (21.1)
 26 87 18 (20.7)
Hygiene characteristics
Toilet type
Flushing toilet 75 15 (20.0)
Pit latrine 105 22 (21.0)
Bush/Other 22 5 (22.7)
Mode of cleaning after visiting the toilet
Tissue paper/other solid materials 64 7 (10.9)
Water 138 35 (25.4)
Vaginal washing when bathing ‡
External 32 6 (18.8)
Internal 166 35 (21.1)
Behavioral characteristics
Sexual debut age (years)
 17 64 21 (32.8)
 18 96 14 (14.6)
Don’t know/no response 42 7 (16.7)
Number of lifetime sex partners
1 96 16 (16.7)
(Continued )
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Table 1. (Continued)
Total
n = 202
Positive for curable STIs n = 42
(%)
2+ 106 26 (24.5)
Partner had other sexual partners in the last 6
months
No 182 38 (20.9)
Yes 20 4 (20.0)
Alcohol consumption ever
No 160 35 (21.9)
Yes 42 7 (16.7)
Tobacco smoking/chewing ever
No 191 41 (21.5)
Yes 11 1 (9.1)
Drugs/substance use ever
No 194 39 (20.1)
Yes 8 3 (37.5)
Sexually transmitted infections/ reproductive tract
infection
HIV
Negative 189 39 (20.6)
Positive 13 3 (23.1)
Syphilis***
Negative 198 42 (21.2)
Positive 2 0 (0.0)
Bacterial vaginosis*
Negative 162 29 (17.9)
Positive 39 13 (33.3)
Clinical signs and symptoms of STI¥
Previous history of vaginal discharge
No 75 13 (17.3)
Yes 127 29 (22.8)
Previous syndromic treatment of genital infection
No 136 28 (20.6)
Yes 66 14 (21.2)
Current vaginal discharge (self-reported)
No 52 10 (19.2)
Yes 149 32 (21.5)
Abnormal vaginal discharge foul smell/color
(observed)
No 165 32 (19.4)
Yes 36 10 (27.8)
Dysuria
No 159 32 (20.1)
Yes 42 10 (23.8)
Dyspareunia
No 150 29 (19.3)
Yes 51 13 (25.5)
Vaginal itching
No 146 31 (21.2)
Yes 55 11 (20.0)
(Continued )
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discharge/foul smelling discharge/colored discharge) upon examination. Five (2.5%) women
had genital ulcers upon examination, of which 4 (9.6%) of the 42 women with a curable STI vs.
1 (0.6%) of the 159 women without a curable STI (p = 0.001). None of the women with genital
ulcers had HIV or treponemal antibodies. Other self-reported clinical signs or symptoms were
not associated with curable STIs.
Based on symptoms routinely used in syndromic management of STIs (i.e. genital ulcer,
lower abdominal pain or abnormal vaginal discharge), 45.2% of the 42 women with curable
STIs were asymptomatic.
Risk factors/predictors
In bivariable analysis, curable STIs were more common among participants who were24
years, had less than 3 children, had a sexual debut17 years, used water to clean themselves
after visiting the toilet, had a genital ulcer or were BV positive (Table 2).
In multivariable analysis, independent predictors associated with curable STIs included
women with a genital ulcer (AOR = 35.0, 95% CI: 2.7–461.6) compared to women without a
genital ulcer, women who used water for cleaning after visiting the toilet compared to those
who used toilet paper or other solid materials (AOR = 4.1, 95% CI: 1.5–11.3), women who
reported having sexual debut17 years compared to women having sexual debut18 years
(AOR = 2.7, 95% CI: 1.1–6.6), and BV-positive women (AOR = 2.7, 95% CI: 1.1–6.6) com-
pared to BV-negative women (Table 2).
Discussion
We found that one in five out of 202 pregnant women attending the ANC at the Kilifi County
Hospital, Kenya, during the period July to September 2015 had at least one curable STI. The
Table 1. (Continued)
Total
n = 202
Positive for curable STIs n = 42
(%)
Lower abdominal pain
No 107 24 (22.4)
Yes 94 18 (19.1)
Genital warts
No 196 40 (20.4)
Yes 5 2(40.0)
Genital ulcer (observed)
No 196 38 (19.4)
Yes 5 4 (80.0)
Vaginitis
No 195 40 (20.5)
Yes 6 2 (33.3)
Curable STIs = Infection with any of the following sexually transmitted infectious agents: Chlamydia
trachomatis, Neisseria gonorrheae and/or Trichomonas vaginalis
‡ Four participants did not respond to this question
*Bacterial vaginosis result for one participant was not available
** Gestational age for one participant was missing
*** Syphilis hospital records for two participants were unavailable.
¥Clinical signs and symptoms of STI records for one participant were missing.
https://doi.org/10.1371/journal.pone.0175166.t001
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Table 2. Bivariable and multivariable analysis of socio-demographic, hygienic, behavioral, and clinical characteristics of pregnant women with
curable sexually transmitted infections attending antenatal clinic at Kilifi County Hospital, July—September 2015 (n = 202).
CurableSTIs n(%) Bivariable analysis Multivariable analysis
Demographic characteristics COR (95% C.I) P-
value
AOR (95% C.I) P-value
Age group (Years)
18–24 24 (29.3) 2.3 (1.2–4.7) 0.016 1.8 (0.7–4.4) 0.226
 25 18 (15.0) Ref
Religion
Christian 28 (19.2) Ref
Muslim 7 (25.0) 1.4 (0.5–3.6) 0.483 - -
Other/None 7 (25.0) 1.4 (0.5–3.6) 0.483 - -
Education
None 7 (20.0) Ref
Primary 26 (22.0) 1.1 (0.4–2.9) 0.797 - -
Secondary/Tertiary 9 (18.4) 0.9 (0.3–2.7) 0.851 - -
Marital status
Single 5 (38.5) Ref
Married 37 (19.6) 0.4 (0.1–1.3) 0.115 - -
Residency
Living with partner 27 (19.6) Ref
Not living with partner 15 (23.4) 1.3 (0.6–2.6) 0.529 - -
Employment status
Employed/self-employed 20 (17.4) Ref
Unemployed 22 (25.3) 1.6 (0.8–3.2) 0.173 - -
Parity
0 15 (25.9) 2.3 (0.9–5.5) 0.071 2.7 (0.8–8.9) 0.111
1–2 17 (24.6) 2.1 (0.9–5.0) 0.087 1.9 (0.7–5.2) 0.237
3+ 10 (13.3) Ref
Gestational age (weeks)
14–25 23 (20.5) Ref
 26 18 (20.7) 1.0 (0.5–2.0) 0.979 - -
Hygiene characteristics
Toilet type
Flushing toilet 15 (20.0) Ref
Pit latrine 22 (21.0) 1.1 (0.5–2.2) 0.876 - -
Bush/Other 5 (22.7) 1.2 (0.4–3.7) 0.781 - -
Mode of cleaning after visiting the toilet
Tissue paper/other solid material 7 (10.9) Ref
Water 35 (25.4) 2.8 (1.2–6.6) 0.022 4.1 (1.5–11.3) 0.007
Vaginal washing when bathing*
External 6 (18.8) Ref
Internal 35 (21.1) 1.2 (0.4–3.0) 0.766 - -
Behavioral characteristics
Sexual debut age (years)
 17 21 (32.8) 2.9 (1.3–6.2) 0.007 2.7 (1.1–6.6) 0.026
 18 14 (14.6) Ref
Don’t know/no response 7 (16.7) 1.2 (0.4–3.2) 0.754 - -
Number of lifetime sex partners
1 16 (16.7) Ref
(Continued )
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Table 2. (Continued)
CurableSTIs n(%) Bivariable analysis Multivariable analysis
Demographic characteristics COR (95% C.I) P-
value
AOR (95% C.I) P-value
2 26 (24.5) 1.6 (0.8–3.3) 0.171 - -
Partner has had other sexual partner(s) in the last 6 months
No 38 (20.9) 1.1 (0.3–3.3) 0.927 - -
Yes 4 (20.0) Ref
Alcohol consumption ever
No 35 (21.9) 1.4 (0.6–3.4) 0.461 - -
Yes 7 (16.7) Ref
Tobacco smoking/chewing ever
No 41 (21.5) 2.7 (0.3–22.0) 0.344 - -
Yes 1 (9.1) Ref
Drugs/Substance use ever
No 39 (20.1) 0.4 (0.1–1.8) 0.248 - -
Yes 3 (37.5) Ref
Clinical characteristics
HIV status
Negative 39 (20.6) Ref
Positive 3 (23.1) 1.2 (0.3–4.4) 0.834 - -
Bacterial vaginosis
Negative 29 (17.9) Ref
Positive 13 (33.3) 2.3 (1.1–5.0) 0.036 2.7 (1.1–6.6) 0.031
Clinical signs and symptoms of STI
Previous history of vaginal discharge
No 13 (17.3) Ref
Yes 29 (22.8) 1.4(0.7–2.9) 0.353 - -
Previous syndromic treatment of genital infection
No 28 (20.5) Ref
Yes 14 (21.2) 1.0 (0.5–2.1) 0.918 - -
Current vaginal discharge (self-reported)
No 10 (19.2) Ref
Yes 32 (21.5) 1.1 (0.5–2.5) 0.732 - -
Abnormal vaginal discharge (observed)
No 32 (19.4) Ref
Yes 10 (27.8) 1.6 (0.7–3.6) 0.265 - -
Dysuria
No 32 (20.1) Ref
Yes 10 (23.8) 1.2 (0.6–2.8) 0.602 - -
Dyspareunia
No 29 (19.3) Ref
Yes 13 (25.5) 1.4 (0.7–3.0) 0.352 - -
Vaginal itching
No 31 (21.2) Ref
Yes 11 (20.0) 0.9 (0.4–2.0) 0.848 - -
Lower abdominal pain
No 24 (22.4) Ref
Yes 18 (19.1) 0.8 (0.4–1.6) 0.568 - -
Genital warts
No 40 (20.4) Ref
Yes 2 (40.0) 2.6 (0.4–16.1) 0.304 - -
(Continued )
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high burden of curable STIs was mostly due to cases of C. trachomatis (14.9% of women) and
T. vaginalis (7.4% of women). We also found approximately 19.4% of the women to have BV,
defined as the presence of vaginal discharge in combination with a Nugent score7. Four out
of the 5 women with genital ulcers also had a curable STI. Our study documented that having
genital ulcers, cleaning with water as opposed to use of toilet paper after visiting the toilet,
early sexual debut, and BV were strongly associated with the presence of curable STIs.
The high prevalence (14.9%) of C. trachomatis found in this study is comparable to a preva-
lence of 13% (95% CI: 8.6–16.8) among women seeking family planning services in Nairobi,
Kenya [20] and 9.9% (95% CI: 7.2–13.2) among women in a multi-country (Kenya, Rwanda
and South Africa) cross-sectional study [26]. Two other recent studies reported lower preva-
lence rates of C. trachomatis: 5.6% (95% CI: 4.4–7.0) among 1300 HIV-seronegative ANC-
attending women at two district hospitals in rural western Kenya [13], and 6.0% (95% CI: 3.6–
9.3) in another study among 300 women attending outpatient clinics in Nairobi [27]. Since the
high prevalence of C. trachomatis among pregnant women may likely reflect ongoing trans-
mission of C. trachomatis among the general rural population in Kilifi, further studies con-
firming the high prevalence and ongoing C. trachomatis transmission among this population
would be helpful. Chlamydia infection has been found to be an independent predictor of HIV-
1 acquisition in a recent study from western Kenya, with also syphilis, yeast infection/colonisa-
tion and BV showing strong associations with incident HIV-1 infection [13].
We documented a prevalence of T. vaginalis (7.4%) comparable to 6.0% among HIV-sero-
negative ANC-attending women in rural western Kenya [13], and 7.7% among women attend-
ing a child-health clinic in Mombasa, Kenya [28]. In vitro evidence suggests that T. vaginalis
may alter the vaginal microbiome towards BV [29]. T. vaginalis has also been associated with
increased viral shedding and increased acquisition of HIV [30, 31], potentially contributing to
a significant number of additional HIV infections globally [31].
The prevalence of HIV-1 (6.4%) in this study was substantial, with all known and newly diag-
nosed cases occurring amongst the 120 women25 years. In Coastal Kenya, HIV-1 prevalence
estimates in women aged 15–24 years decreased from 5.7% in 2007 to 2.0% in 2012 (p = 0.026)
[32]. Our results suggest a further decline in HIV-1 prevalence, among women 24 years.
Table 2. (Continued)
CurableSTIs n(%) Bivariable analysis Multivariable analysis
Demographic characteristics COR (95% C.I) P-
value
AOR (95% C.I) P-value
Genital ulcer (observed)
No 38 (19.4) Ref
Yes 4 (80.0) 16.6 (1.8–153.1) 0.013 35.0 (2.7–461.6) 0.031
Vaginitis
No 40 (20.5) Ref
Yes 2 (33.3) 1.9 (0.3–11.0) 0.454 - -
Curable STI = Infection with any of the following sexually transmitted infectious agents: Chlamydia trachomatis, Neisseria gonorrheae, Trichomonas
vaginalis
AOR: Adjusted Odds Ratio
CI: Confidence interval
COR: Crude Odds Ratio
*One participant did not respond to this question
https://doi.org/10.1371/journal.pone.0175166.t002
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A relatively low prevalence of N. gonorrhoeae (1%) and treponemal antibodies (1%) were
found in our study. The prevalence of treponemal antibodies was similar to the study among
HIV-seronegative ANC-attending women in rural western Kenya, [13] while the N. gonor-
rhoeae prevalence in the latter study was 3.0%.
BV diagnosis in our study was based on an a priori self-report of vaginal discharge in combi-
nation with a Nugent score of7 (while only 2 (1%) women had asymptomatic BV). Women
with BV had an almost 3-fold higher risk of infection with a curable STIs than women without
BV, comparable to other studies [4, 33]. It might be advisable to better document the presence
of BV. However, general screening for BV among all women attending ANC, using the Nugent
score [23] or Amsel’s criteria [34], would require significant commitment of resources and staff.
Using simple point of care testing, Madhivanan et al. [35] demonstrated that a vaginal pH>4.5
and a positive whiff test had a sensitivity of 83% but a specificity of only 47% for diagnosing BV.
Although, not specific this approach may be adopted for BV screening in resource poor settings.
Alternatively, presumptive treatment with intravaginal metronidazole (750 mg) plus micona-
zole (200 mg) for five consecutive nights each month for 12 months was shown to be effective
to improve vaginal health and to decrease susceptibility to bacterial STIs, in a recent trial among
non-pregnant women [36], but the frequency of treatment would make it challenging to upscale
this intervention.
Our findings reinforce the need to integrate STI services at ANC. Screening for T. vaginalis
can be achieved at a relatively affordable cost (US $ 5), making screening for T. vaginalis po-
tentially feasible. Recent acquisition by the Kenyan government of over 120 GeneXpert IV
machines for county and sub-county hospitals for tuberculosis testing [37], has potentially
expanded the diagnostic capacity for curable STIs using the same testing platform at larger
hospitals. However, the cost of the C. trachomatis and N. gonorrhoeae test kits are currently
high. Without assay costs becoming considerably less expensive, it seems unlikely that ANC-
attending women will be routinely tested for C. trachomatis and N. gonorrhoeae. Cost-effective
studies have played an important role of informing policy on the gains of syphilis screening in
pregnancy while minimizing on the expenditure [38]. Such cost-effectiveness studies of ANC
screening and treatment of C. trachomatis, N. gonorrhoeae, and T. vaginalis should be con-
ducted in resource poor settings.
Treatment of STIs in both infected persons and their partner is pivotal for STI management,
ensuring reduction in cases of reinfection or non-resolving infections and prevention of adverse
outcomes [8]. In our study a presumptive patient delivered partner treatment approach was
adopted. Despite the fact that we did not collect information on the number of partners who
were treated, this approach has been shown to be acceptable and feasible among pregnant
women in Kenya [39].
Early sexual debut was strongly associated with curable STIs in our study population, simi-
lar to findings in other studies [40, 41]. Kilifi county is one of the poorest counties in Kenya,
characterized by low literacy levels mostly among women, young age at marriage of women,
and high fertility rates [42]. Structural changes focusing on the economic empowerment of
communities, including improved access to education, and legislation protecting women from
early marriage will be necessary to reduce the high burden of curable STIs among pregnant
women.
A salient predictor of curable STIs in our study population was the use of water to clean after
visiting the toilet as compared to those women who reported to use toilet paper or other solid
materials. Unfortunately, our hygiene question did not distinguish urinating from defecating,
or inquired whether the cleaning mode included both anus and vagina. It is possible that such
cleaning transported bacteria from the perianal area to the vagina, as pathogens causing curable
STIs may be found in paragenital areas [43]. Moreover, there is a strong correspondence in
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bacterial species and loads between the vagina and rectum of pregnant women [44]. McClelland
et.al [31] showed that vaginal washing increased risk of HIV-1 acquisition among African
women. Although, we did not assess whether water used by our study participants was shared,
sharing of water may potentially lead to contamination of the vagina [45]. Pereira-Neves and
Benchimol [46] showed in vitro that T. vaginalis remained viable and infective in swimming
pool water samples for several hours. Further research is required to investigate the potential
role that sanitary and hygiene practices may play in women with high prevalence of curable
STIs and BV.
Observed genital ulcers had the strongest association with curable STIs, and were found in
2.5% of study participants. Presumptively treating curable STIs on the basis of observed genital
ulcers in pregnant women would have treated ~10% of the curable STIs in our study. Studies
examining microbial aetiology of genital ulcer disease, have shown that genital ulcers can be
attributed to several sexually transmitted pathogens with most cases being attributed to Herpes
Simplex virus type 2 [47, 48]. Genital ulcers were also identified as the strongest predictor of
acute HIV acquisition in attendees of STD clinics who initially had HIV-seronegative or dis-
cordant rapid test results [49]. While in our study no women with genital ulcers had HIV,
observing genital ulcers in women may help initiate risk reduction during ANC counselling
and targeted acute HIV screening [50].
Our study had some limitations. First, our study only included a relatively small sample of
pregnant women limiting the precision of our prevalence estimates. Second, we only included
adult women and were not able to enroll pregnant women who were minors. Minors are
potentially more vulnerable and may have presented with different STIs. Third, we included
only women residing within the Kilifi Health and Demographic Surveillance Area [22], and
therefore will have excluded women from outside the surveillance area who may have different
health characteristics. Fourth, our hygiene and sanitary questions were few, and limited [51].
Finally, this was a cross-sectional study, only allowing for an assessment of associations and
we did not collect data on pregnancy outcomes.
Despite these limitations, we showed that there is high prevalence of curable STIs among
pregnant women attending an antenatal clinic at Kilifi County Hospital, Kenya. Curable STIs
were associated with genital ulcers, hygienic practices, early sexual debut and BV. We recom-
mend that antenatal care programs consider strengthening their diagnostic screening for cur-
able STIs and BV.
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